ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $590,238 | -31.5% | 53,903 | -17.1% | 0.00% | 0.0% |
| Q2 2023 | $861,050 | +44.5% | 65,034 | +48.6% | 0.00% | 0.0% |
| Q1 2023 | $595,696 | +63.6% | 43,769 | +134.8% | 0.00% | +100.0% |
| Q4 2022 | $364,059 | -3.7% | 18,641 | -6.1% | 0.00% | 0.0% |
| Q3 2022 | $378,000 | +12.2% | 19,847 | +21.2% | 0.00% | 0.0% |
| Q2 2022 | $337,000 | -61.1% | 16,379 | -39.1% | 0.00% | -50.0% |
| Q1 2022 | $866,000 | -30.8% | 26,900 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,252,000 | +209.1% | 26,900 | +79.3% | 0.00% | +100.0% |
| Q3 2021 | $405,000 | +5.2% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $385,000 | -25.0% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $513,000 | +1.2% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $507,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |